NASDAQ · Biotechnology

iBio, Inc. Common Stock (IBIO)

$1.05 -6.25%

Add alert

29 Oversold Daily RSI (14) · 6 Oct 2026

Moving averages

SMA 200$1.85-43.24%

Company profile

iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States. The company is headquartered in New York, New York.

SectorHealthcare

IndustryBiotechnology

Market cap$77.49M

P/E ratioNone

EPS$-0.32

Beta1.291

Dividend yield0.00%

52-week high$3.82

52-week low$0.77

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 43 VRTX Vertex Pharmaceuticals Inc RSI 38 CRSP CRISPR Therapeutics AG RSI 46 IOVA Iovance Biotherapeutics Inc RSI 66 MRNA Moderna Inc RSI 71 VKTX Viking Therapeutics Inc RSI 41 SRPT Sarepta Therapeutics Inc RSI 38 EDIT Editas Medicine Inc RSI 51 IBRX ImmunityBio Inc RSI 71 NVAX Novavax Inc RSI 77

Free forever

RSI alerts for IBIO

Get an email the moment iBio, Inc. Common Stock crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 13 September 2026 at 7:37 AM EDT